717
Participants
Start Date
August 12, 2021
Primary Completion Date
March 25, 2027
Study Completion Date
March 25, 2027
DUPIXENT®
No investigational agents will be provided. All treatments will be prescribed at the discretion of the study physician and other healthcare providers.
Amsterdam UMC location AMC, Amsterdam
Alrijne Ziekenhuis, Leiderdorp
Charité, Berlin
Montefiore Medical Center, New York
Northwell Health, Great Neck
Rochester Regional Health System, Rochester
University of Rochester Medical Center, Rochester
ENT Clinic San Martino Hospital, Genova
Oberhavelkliniken Hennigsdorf, Hennigsdorf
Istituto Clinico Humanitas, Rozzano
John Hopkins University School Of Medicine, Baltimore
University of Virginia Health System (UVA), Charlottesville
Richmond Ear Nose & Throat, Richmond
Eastern Virginia Medical School, Norfolk
Wake Forest Baptist Health, Winston-Salem
Allergy Partners of the Triangle, Raleigh
Duke University Medical Center, Durham
Spartanburg Ear, Nose & Throat Clinical, Spartanburg
Medical University Of South Carolina, Charleston
ENT & Allergy Partners, Summerville
ADAC research, PA, Greenville
Emory University Hospital Midtown, Atlanta
IACT Health, Columbus
University of Florida, Gainesville
Damask Physicians Group, Lake Mary
AADRS Clincial Research Center, Coral Gables
University of South Florida, Tampa
AOU di Padova, Padua
Excel ENT of Alabama, Birmingham
Vanderbilt University Medical Center, Nashville
Universitätsklinikum Düsseldorf, Düsseldorf
University of Cincinnati College of Medicine, Cincinnati
Indiana University Health, Indianapolis
University Hospital Münster, Münster
Azienda Ospedaliero Universitaria Senese, Siena
Allergy & Asthma Center of Minnesota - Allergology, Maplewood
Universita Degli Studi di Pisa Ospedale di Cisanello Pisa, Pisa
Asthma & Allergy Center of Chicago, Oak Park
Northwestern University Feinberg School of Medicine, Chicago
University of Illinois, Chicago
The University of Chicago Medical Center UCMC Duchossois Center for Advanced Medicine DCAM, Chicago
Zentrum für Rhinologie, Wiesbaden
University of Missouri, Columbia
University Hospital Mannheim - Dermatology, Venerology, Allergology, Mannheim
University of Nebraska Medical Center, Omaha
Essential Medical Research, Tulsa
STAAMP Research, San Antonio
Treasure Valley Medical Research, Boise
Tanner Clinic, Layton
Medical Research of Arizona, a division of Allergy, Asthma & Immunology Associates, Scottsdale
Università Degli Studi Magna Graecia di Catanzaro, Catanzaro
Breathe Clear Institute, Torrance
ARK Clinical Research, Long Beach
The Allergy and Rheumatology Medical Clinic, La Jolla
Scripps Health - Scripps Clinic Carmel Valley, San Diego
Allergy & Asthma Clinical Research, Walnut Creek
Azienda Ospedaliero Universitara Policlinico di Catania, Catania
The Vancouver Clinic, Vancouver
Brigham & Women's Hospital, Boston
University of Michigan, Michigan Medicine Pulmonary Clinic, Ann Arbor
Atlantic Research Center LLC, Ocean City
Asthma, Nasal Disease & Allergy Research Center of New England, East Providence
Allergy and Asthma Physicians of RI, Lincoln
ENT Clinic Sinus Center, St. Paul's Hospital, Vancouver
Dr. Richard Gall Med Corp, Winnipeg
Toronto Allergy & Asthma Clinic-Pulmonology, Toronto
Centre hospitalier de l'Université de Montréal, Montreal
Hopital Du Saint-Sacrement, Québec
Praxis Dr. Yury Yarin, Dresden
Universitätsklinikum Jena, Jena
"Azienda Policlinico Umberto I - Università degli Studi di Roma La Sapienza", Rome
Fondazione universitaria Policlinico A. Gemelli, Rome
Azienda Ospedaliero Universitaria di Sassari, Sassari
University of Fukui Hospital - Otorhinolaryngology, Yoshida-gun
Fujisawa City Hospital, Fujisawa
Nagaoka Red Cross Hospital - Otorhinolaryngology, Nagaoka
Osaka Haibikino Medical Center, Habikino
Tokyo Kyosai Hospital, Meguro-Ku
Matsuwaki Clinic Shinagawa, Shinagawa-Ku
Kyoto Nose & Allergy Clinic, Kyoto
Onze Lieve Vrouwe Gasthuis, Amsterdam
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY